Industry: Healthcare
Published Date: January-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 194
Report ID: PMRREP33942
1. Executive Summary
1.1. Global DNA Synthesis Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Service Type Lifecycle Analysis
2.4. DNA Synthesis Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global DNA Synthesis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2019-2026
3.3. Global DNA Synthesis Market Outlook: Service Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Service Type, 2019 - 2023
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2024 - 2031
3.3.3.1. Oligonucleotide
3.3.3.2. Universal Oligonucleotide
3.3.3.3. Custom Oligonucleotide
3.3.3.4. Gene
3.3.3.5. Custom Gene
3.3.3.6. Gene Library
3.4. Market Attractiveness Analysis: Service Type
3.5. Global DNA Synthesis Market Outlook: Application
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2019 - 2023
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
3.5.3.1. Research and Development
3.5.3.2. Academic Applications
3.5.3.3. Industrial Applications
3.5.3.4. Diagnosis
3.5.3.5. Therapeutics
3.6. Market Attractiveness Analysis: Application
3.7. Global DNA Synthesis Market Outlook: End User
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2019 - 2023
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
3.7.3.1. Biopharmaceutical Companies
3.7.3.2. Academic and Research Institutes
3.7.3.3. Contract Research Organizations
3.8. Market Attractiveness Analysis: End User
4. Global DNA Synthesis Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2019 - 2023
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2024 - 2031
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America DNA Synthesis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
5.3.1. By Country
5.3.2. By Service Type
5.3.3. By Application
5.3.4. By End User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2024 - 2031
5.5.1. Oligonucleotide
5.5.2. Universal Oligonucleotide
5.5.3. Custom Oligonucleotide
5.5.4. Gene
5.5.5. Custom Gene
5.5.6. Gene Library
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
5.6.1. Research and Development
5.6.2. Academic Applications
5.6.3. Industrial Applications
5.6.4. Diagnosis
5.6.5. Therapeutics
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
5.7.1. Biopharmaceutical Companies
5.7.2. Academic and Research Institutes
5.7.3. Contract Research Organizations
5.8. Market Attractiveness Analysis
6. Europe DNA Synthesis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
6.3.1. By Country
6.3.2. By Service Type
6.3.3. By Application
6.3.4. By End User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2024 - 2031
6.5.1. Oligonucleotide
6.5.2. Universal Oligonucleotide
6.5.3. Custom Oligonucleotide
6.5.4. Gene
6.5.5. Custom Gene
6.5.6. Gene Library
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
6.6.1. Research and Development
6.6.2. Academic Applications
6.6.3. Industrial Applications
6.6.4. Diagnosis
6.6.5. Therapeutics
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
6.7.1. Biopharmaceutical Companies
6.7.2. Academic and Research Institutes
6.7.3. Contract Research Organizations
6.8. Market Attractiveness Analysis
7. East Asia DNA Synthesis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
7.3.1. By Country
7.3.2. By Service Type
7.3.3. By Application
7.3.4. By End User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2024 - 2031
7.5.1. Oligonucleotide
7.5.2. Universal Oligonucleotide
7.5.3. Custom Oligonucleotide
7.5.4. Gene
7.5.5. Custom Gene
7.5.6. Gene Library
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
7.6.1. Research and Development
7.6.2. Academic Applications
7.6.3. Industrial Applications
7.6.4. Diagnosis
7.6.5. Therapeutics
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
7.7.1. Biopharmaceutical Companies
7.7.2. Academic and Research Institutes
7.7.3. Contract Research Organizations
7.8. Market Attractiveness Analysis
8. South Asia & Oceania DNA Synthesis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
8.3.1. By Country
8.3.2. By Service Type
8.3.3. By Application
8.3.4. By End User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2024 - 2031
8.5.1. Oligonucleotide
8.5.2. Universal Oligonucleotide
8.5.3. Custom Oligonucleotide
8.5.4. Gene
8.5.5. Custom Gene
8.5.6. Gene Library
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
8.6.1. Research and Development
8.6.2. Academic Applications
8.6.3. Industrial Applications
8.6.4. Diagnosis
8.6.5. Therapeutics
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
8.7.1. Biopharmaceutical Companies
8.7.2. Academic and Research Institutes
8.7.3. Contract Research Organizations
8.8. Market Attractiveness Analysis
9. Latin America DNA Synthesis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
9.3.1. By Country
9.3.2. By Service Type
9.3.3. By Application
9.3.4. By End User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2024 - 2031
9.5.1. Oligonucleotide
9.5.2. Universal Oligonucleotide
9.5.3. Custom Oligonucleotide
9.5.4. Gene
9.5.5. Custom Gene
9.5.6. Gene Library
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
9.6.1. Research and Development
9.6.2. Academic Applications
9.6.3. Industrial Applications
9.6.4. Diagnosis
9.6.5. Therapeutics
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
9.7.1. Biopharmaceutical Companies
9.7.2. Academic and Research Institutes
9.7.3. Contract Research Organizations
9.8. Market Attractiveness Analysis
10. Middle East & Africa DNA Synthesis Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2019 - 2023
10.3.1. By Country
10.3.2. By Service Type
10.3.3. By Application
10.3.4. By End User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2024 - 2031
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Service Type, 2024 - 2031
10.5.1. Oligonucleotide
10.5.2. Universal Oligonucleotide
10.5.3. Custom Oligonucleotide
10.5.4. Gene
10.5.5. Custom Gene
10.5.6. Gene Library
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2024 - 2031
10.6.1. Research and Development
10.6.2. Academic Applications
10.6.3. Industrial Applications
10.6.4. Diagnosis
10.6.5. Therapeutics
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2024 - 2031
10.7.1. Biopharmaceutical Companies
10.7.2. Academic and Research Institutes
10.7.3. Contract Research Organizations
10.8. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2023
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition Analog IC
11.2.3. Apparent Service Type Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Brooks Automation, Inc. (GENEWIZ)
11.3.1.1. Overview
11.3.1.2. Segments and Service Type
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Boster Biological Technology
11.3.2.1. Overview
11.3.2.2. Segments and Service Type
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. ProteoGenix
11.3.3.1. Overview
11.3.3.2. Segments and Service Type
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Biomatik
11.3.4.1. Overview
11.3.4.2. Segments and Service Type
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. ProMab Biotechnologies, Inc
11.3.5.1. Overview
11.3.5.2. Segments and Service Type
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Thermo Fisher Scientific, Inc
11.3.6.1. Overview
11.3.6.2. Segments and Service Type
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Integrated DNA Technologies, Inc
11.3.7.1. Overview
11.3.7.2. Segments and Service Type
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. OriGene Technologies, Inc
11.3.8.1. Overview
11.3.8.2. Segments and Service Type
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations